AETHLON MEDICAL INC (AEMD)
Aethlon Medical Inc. (AEMD) is a biotechnology company focused on developing therapeutic and diagnostic technologies for infectious disease and cancer. The company is known for its Hemopurifier, a device designed to capture and remove viruses, tumor-derived antigens, and other pathogenic substances from the blood. Aethlon aims to address unmet medical needs through its innovative biofiltration and immunotherapy-based platforms.
Company News
Promeza MG has been contracted by AETH to provide marketing services for a theological conference addressing migration, preaching, and pastoral care, taking place in October 2025 at Life Pacific University.
Aethlon Medical has priced a public offering of 5 million shares and warrants at $0.90 per share, expecting to raise approximately $4.5 million for general corporate purposes including clinical trials and research.
Trading options with penny stocks? Here's what you need to kno The post Strategies for Trading Options With Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.